97
Views
25
CrossRef citations to date
0
Altmetric
Review

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD

, , &
Pages 253-263 | Published online: 30 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mayank Ajmera, Chan Shen, Xiaoyun Pan, Patricia A Findley, George Rust & Usha Sambamoorthi. (2013) Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 287-294.
Read now
Mario Cazzola, Clive P Page & Maria Gabriella Matera. (2013) Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:9, pages 1205-1214.
Read now
Adolfo Baloira. (2013) Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?. Expert Review of Respiratory Medicine 7:sup2, pages 17-24.
Read now
Ekaterina S Gladysheva, Atul Malhotra & Robert L Owens. (2010) Influencing the decline of lung function in COPD: use of pharmacotherapy. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 153-164.
Read now
Eric Bateman, Dave Singh, David Smith, Bernd Disse, Lesley Towse, Dan Massey, Jon Blatchford, Demetri Pavia & Rick Hodder. (2010) Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 197-208.
Read now

Articles from other publishers (20)

A. Calderón Montero. (2023) El eje cardiopulmonar y la mortalidad cardiovascular en el paciente EPOC. Medicina de Familia. SEMERGEN 49:4, pages 101928.
Crossref
Junli Guo, Yuanyuan Zhang, Tianxiao Liu, Bruce D. Levy, Peter Libby & Guo-Ping Shi. (2022) Allergic asthma is a risk factor for human cardiovascular diseases. Nature Cardiovascular Research 1:5, pages 417-430.
Crossref
Klaus F. Rabe, John R. Hurst & Samy Suissa. (2018) Cardiovascular disease and COPD: dangerous liaisons?. European Respiratory Review 27:149, pages 180057.
Crossref
A. Gillissen, Christian M. Kähler, A. Rembert Koczulla, Rüdiger Sauer & Maria Paparoupa. (2017) Aktuelle Therapieoptionen bei der COPDCOPD-Management, a comprehensive review. MMW - Fortschritte der Medizin 159:S3, pages 32-43.
Crossref
Damilola T. Adesanoye & Cynthia J. Willey. (2017) Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?. Annals of Pharmacotherapy 51:10, pages 855-861.
Crossref
Chang-Hoon Lee, Seongmi Choi, Eun Jin Jang, Dong-Wook Kim, Ho Il Yoon, Yun Jung Kim, Jimin Kim, Jae-Joon Yim & Deog Kyeom Kim. (2016) The effects of inhaled respiratory drugs on the risk of stroke: A nested case-control study. Pulmonary Pharmacology & Therapeutics 40, pages 7-14.
Crossref
Deborah Morrison, Karolina Agur, Stewart Mercer, Andreia Eiras, Juan I González-Montalvo & Kevin Gruffydd-Jones. (2016) Managing multimorbidity in primary care in patients with chronic respiratory conditions. npj Primary Care Respiratory Medicine 26:1.
Crossref
Ursula Kirchmayer, Silvia Cascini, Nera Agabiti, Mirko Di Martino, Lisa Bauleo, Giulio Formoso, Claudio Voci, Riccardo Pistelli, Elisabetta Patorno & Marina Davoli. (2016) One‐year mortality associated with COPD treatment: a comparison of tiotropium and long‐acting beta2‐agonists in three Italian regions: results from the OUTPUL study. Pharmacoepidemiology and Drug Safety 25:5, pages 578-589.
Crossref
Sruthi Adimadhyam, Glen T. Schumock, Surrey Walton, Min Joo, Joanne McKell & Todd A. Lee. (2014) Risk of Arrhythmias Associated with Ipratropium Bromide in Children, Adolescents, and Young Adults with Asthma: A Nested Case-Control Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:4, pages 315-323.
Crossref
S. Möhlenkamp, G. Weinreich, T. Neumann, T. Voshaar & H. Teschler. (2014) Medikamentöse Therapie von Herz- und LungenerkrankungenMedical therapy of heart and lung diseases. Herz 39:1, pages 15-24.
Crossref
Arthur F. Gelb, Donald P. Tashkin, Barry J. Make, Xiaoyun Zhong, Esther Garcia Gil & Cynthia Caracta. (2013) Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD. Respiratory Medicine 107:12, pages 1957-1965.
Crossref
Mansi Gupta, Vishal Bansal & Sunil K Chhabra. (2013) Abnormal heart rate recovery and chronotropic incompetence on exercise in chronic obstructive pulmonary disease. Chronic Respiratory Disease 10:3, pages 117-126.
Crossref
Timothy E. Albertson, Michael Schivo, Amir A. Zeki, Samuel Louie, Mark E. Sutter, Mark Avdalovic & Andrew L. Chan. (2013) The Pharmacological Approach to the Elderly COPD Patient. Drugs & Aging 30:7, pages 479-502.
Crossref
Klaus F. Rabe. (2012) Drug Safety in COPD Revisited. Chest 142:2, pages 271-274.
Crossref
Robert J. Mentz, Mona Fiuzat, Monica Kraft, Joann Lindenfeld & Christopher M. O’Connor. (2012) Bronchodilators in Heart Failure Patients With COPD: Is It Time for a Clinical Trial?. Journal of Cardiac Failure 18:5, pages 413-422.
Crossref
Rachael A. Evans, Robert G. Varadi, Kambiz Mirzaei & Roger S. Goldstein. 2012. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease 211 252 .
Kenneth R. Chapman, Stephen I. Rennard, Angeli Dogra, Roger Owen, Cheryl Lassen & Benjamin Kramer. (2011) Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD. Chest 140:1, pages 68-75.
Crossref
Hashir MajidAmir Sharafkhaneh. (2011) The Pharmacotherapy of Chronic Obstructive Pulmonary Disease in the Elderly: An Update. Clinical Medicine Insights: Therapeutics 3, pages CMT.S3408.
Crossref
Keir E. Lewis & Gwyneth A. Davies. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 311 331 .
Vivek Malipatil & Christine F McDonald. (2009) Management of Older People with Chronic Obstructive Pulmonary Disease. Journal of Pharmacy Practice and Research 39:4, pages 302-306.
Crossref